Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trial.
Maxim J P RooijakkersGeert A A VersteegKimberley I HemelrijkHugo M AartsDaniël C OverduinDirk-Jan van GinkelPieter J VlaarMarleen H van WelyLokien X van NunenRobert Jan van GeunsLeen A F M van GarsseGuillaume S C GeuzebroekMichel W A VerkroostLaura RodwellRobin H HeijmenPim A L ToninoJurrien M Ten BergRonak DelewiNiels van RoyenPublished in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2024)
The TAVI XS trial is the first randomised trial comparing an upper extremity approach to a lower extremity approach with regard to clinically relevant secondary access site-related bleeding complications. The results of this trial will provide important insights into the safety and efficacy of an upper extremity approach in patients undergoing transfemoral TAVI.
Keyphrases
- transcatheter aortic valve implantation
- study protocol
- aortic valve
- aortic valve replacement
- aortic stenosis
- clinical trial
- phase iii
- open label
- phase ii
- transcatheter aortic valve replacement
- patients undergoing
- randomized controlled trial
- ejection fraction
- left ventricular
- double blind
- atrial fibrillation
- heart failure
- placebo controlled
- risk factors
- drug induced